Ken Griffin Gsk PLC Transaction History

Citadel Advisors LLC

$505 Billion
Q3 2024

20 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	BUY	$42.05 - $47.77 $6.4 Million - $7.27 Million	152,088 Added 12.81%	1,339,209 $58.3 Million
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $7.14 Million - $8.48 Million	177,586 Added 17.59%	1,187,121 $51.7 Million
Q4 2021 Feb 14, 2022	BUY	$38.88 - $45.31 $20 Million - $23.3 Million	513,369 Added 103.47%	1,009,535 $45.4 Million
Q3 2021 Nov 15, 2021	SELL	$38.79 - $43.16 $6.62 Million - $7.37 Million	-170,695 Reduced 25.6%	496,166 $19 Million
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $16.1 Million - $18.3 Million	-441,582 Reduced 39.84%	666,861 $27.1 Million
Q1 2021 May 17, 2021	BUY	$34.27 - $40.01 $35.1 Million - $41 Million	1,024,627 Added 1222.47%	1,108,443 $39.6 Million
Q4 2020 Feb 16, 2021	SELL	$34.07 - $39.94 $10.2 Million - $11.9 Million	-298,809 Reduced 78.09%	83,816 $3.09 Million
Q3 2020 Nov 16, 2020	BUY	$38.11 - $42.99 $13.4 Million - $15.1 Million	351,792 Added 1140.96%	382,625 $14.4 Million
Q2 2020 Aug 14, 2020	SELL	$37.87 - $43.58 $13.1 Million - $15.1 Million	-347,219 Reduced 91.84%	30,833 $1.26 Million
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $11 Million - $16.5 Million	337,994 Added 843.76%	378,052 $14.3 Million
Q4 2019 Feb 14, 2020	SELL	$42.0 - $48.25 $1.01 Million - $1.16 Million	-23,973 Reduced 37.44%	40,058 $1.88 Million
Q3 2019 Nov 14, 2019	SELL	$40.46 - $43.52 $4.15 Million - $4.46 Million	-102,579 Reduced 61.57%	64,031 $2.79 Million
Q2 2019 Aug 14, 2019	SELL	$39.4 - $42.7 $14.3 Million - $15.4 Million	-361,783 Reduced 68.47%	166,610 $6.67 Million
Q1 2019 May 15, 2019	BUY	$38.57 - $42.69 $14.2 Million - $15.8 Million	369,357 Added 232.25%	528,393 $0
Q4 2018 Feb 14, 2019	SELL	$37.8 - $42.69 $3.02 Million - $3.41 Million	-79,922 Reduced 33.45%	159,036 $6.2 Million
Q3 2018 Nov 13, 2018	BUY	$39.75 - $42.69 $8.11 Million - $8.71 Million	203,939 Added 582.37%	238,958 $0
Q2 2018 Aug 10, 2018	SELL	$39.61 - $42.76 $2.93 Million - $3.17 Million	-74,075 Reduced 67.9%	35,019 $0
Q1 2018 May 11, 2018	SELL	$36.18 - $40.15 $11.2 Million - $12.4 Million	-309,704 Reduced 73.95%	109,094 $4.26 Million
Q4 2017 Feb 09, 2018	SELL	$35.34 - $41.9 $701,852 - $832,134	-19,860 Reduced 4.53%	418,798 $14.9 Million
Q3 2017 Nov 09, 2017	BUY	$39.44 - $41.55 $17.3 Million - $18.2 Million	438,658	438,658 $17.8 Million

Others Institutions Holding GSK

# of Institutions

Shares Held

176K

Call Options Held

Put Options Held

View Full List

About GSK PLC

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $69.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

More about GSK

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account